Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

21. Urinary tract infection (lower) - men

Urinary tract infection (lower) - men Urinary tract infection (lower) - men | Topics A to Z | CKS | NICE Search CKS… Menu Urinary tract infection (lower) - men Urinary tract infection (lower) - men Last revised in November 2018 Urinary tract infection (UTI) is infection of any part of the urinary tract, usually by bacteria. Diagnosis Management Prescribing information Background information Urinary tract infection (lower) - men: Summary Urinary tract infection (UTI) is infection of any part (...) of the urinary tract, usually by bacteria. The commonest uropathogen causing UTI in adults is Escherichia coli in approximately 80% of cases. UTI in men is generally uncommon, but incidence rates are higher in elderly men and those with risk factors, such as: Benign prostatic hypertrophy (BPH) and other causes of urine outflow obstruction (for example, urinary tract stones, urethral stricture). Catheterisation — UTI is the most common hospital acquired infection, and the majority of cases result from

2019 NICE Clinical Knowledge Summaries

22. Urinary tract infection - children

Urinary tract infection - children Urinary tract infection - children | Topics A to Z | CKS | NICE Search CKS… Menu Urinary tract infection - children Urinary tract infection - children Last revised in February 2019 Urinary tract infection (UTI) is illness caused by micro-organisms in the urinary tract. Diagnosis Management Prescribing information Background information Urinary tract infection - children: Summary Urinary tract infection (UTI) is illness caused by micro-organisms in the urinary (...) tract. Most UTIs are caused by bacteria from the gastrointestinal tract. Common organisms causing UTI in children include Escherichia coli (about 85% or more of cases), Klebsiella species, and Staphylococcus saprophyticus . Around 1 in 10 girls and 1 in 30 boys will have had a UTI by the age of 16 years. Overall, the prognosis after childhood UTI is good. However, in people with urinary tract comorbidity, progression of renal dysfunction is likely. Complications can include renal scarring

2019 NICE Clinical Knowledge Summaries

23. Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU

Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU Recurrent uncomplicated urinary tract infections in women: AUA/CUA/SUFU guideline To view this page ensure that Adobe Flash Player version 10.0.0 or greater is installed. Besides, it's possible to , or you can view flippdf Either scripts and active content are not permitted to run or Adobe Flash Player version 10.0.0 or greater is not installed. Besides, it's possible to , or you can view flippdf

2019 Canadian Urological Association

24. Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial Full Text available with Trip Pro

Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial Increased hydration is often recommended as a preventive measure for women with recurrent cystitis, but supportive data are sparse.To assess the efficacy of increased daily water intake on the frequency of recurrent cystitis in premenopausal women.Randomized, open-label, controlled, 12-month trial at a clinical research center (years 2013-2016). Among 163 healthy (...) women with recurrent cystitis (≥3 episodes in past year) drinking less than 1.5 L of fluid daily assessed for eligibility, 23 were excluded and 140 assigned to water or control group. Assessments of daily fluid intake, urinary hydration, and cystitis symptoms were performed at baseline, 6- and 12-month visits, and monthly telephone calls.Participants were randomly assigned to drink, in addition to their usual fluid intake, 1.5 L of water daily (water group) or no additional fluids (control group

2018 EvidenceUpdates

25. Urinary tract infection (lower): antimicrobial prescribing

Urinary tract infection (lower): antimicrobial prescribing Urinary tr Urinary tract infection (lower): act infection (lower): antimicrobial prescribing antimicrobial prescribing NICE guideline Published: 31 October 2018 nice.org.uk/guidance/ng109 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after (...) be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Urinary tract infection (lower): antimicrobial prescribing (NG109) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

26. Urinary tract infection (recurrent): antimicrobial prescribing

Urinary tract infection (recurrent): antimicrobial prescribing Urinary tr Urinary tract infection (recurrent): act infection (recurrent): antimicrobial prescribing antimicrobial prescribing NICE guideline Published: 31 October 2018 nice.org.uk/guidance/ng112 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE (...) in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Urinary tract infection (recurrent): antimicrobial prescribing (NG112) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

27. Rapid diagnostic assay for detection of cellulose in urine as biomarker for biofilm-related urinary tract infections Full Text available with Trip Pro

Rapid diagnostic assay for detection of cellulose in urine as biomarker for biofilm-related urinary tract infections The ability of uropathogenic Escherichia coli (UPEC) to adopt a biofilm lifestyle in the urinary tract is suggested as one cause of recurrent urinary tract infections (UTIs). A clinical role of UPEC biofilm is further supported by the presence of bacterial aggregates in urine of UTI patients. Yet, no diagnostics exist to differentiate between the planktonic and biofilm lifestyle (...) forms biofilm in the urinary tract. Clinical implementation of this rapid, non-invasive and user-friendly optotracing diagnostic assay will potentially aid clinicians in the design of effective antibiotic treatment.

2018 NPJ biofilms and microbiomes

28. Urinary tract infections in children

Urinary tract infections in children Urinary tract infections in children - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Urinary tract infections in children Last reviewed: February 2019 Last updated: October 2018 Summary A common diagnosis among infants and children; if missed, can lead to renal scarring, hypertension, and end-stage renal disease. Non-specific signs and symptoms may herald UTI, and practitioners (...) in the absence of urinary reflux. Definition Paediatric urinary tract infection (UTI) is defined as a common bacterial infection involving the lower urinary tract (cystitis), the upper urinary tract (pyelonephritis), or both, causing illness in children. Recognising and treating these infections promptly and accurately is important. UTI is associated with pyelonephritis, which has potential sequelae, including renal scarring. Untreated UTI can also lead to hypertension and end-stage renal disease

2018 BMJ Best Practice

29. Urinary tract infections in men

Urinary tract infections in men Urinary tract infections in men - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Urinary tract infections in men Last reviewed: February 2019 Last updated: September 2018 Summary Rarely occurs before 50 years of age. Often associated with abnormal structure or function of the urinary tract (complicated UTI). Catheter-associated UTI is the most common cause of nosocomial infection (...) . Imaging of the urinary tract is recommended for men with persistent haematuria, voiding dysfunction without a clearly identifiable cause such as benign prostatic hyperplasia (BPH), failure of initial therapy, or signs of upper tract infection. Should generally be treated with a fluoroquinolone antibiotic for 7 to 14 days. Asymptomatic bacteriuria does not require treatment except before urological procedures. Definition Urinary tract infection (UTI) is an inflammatory reaction of the urinary tract

2018 BMJ Best Practice

30. Urinary tract infection

for: Søk Menu • • Systematic reviews on preventing catheter-associated urinary tract infection Søk i Folkehelsa.no Search for: Søk Infectious diseases & Vaccines Close Mental & Physical health Close Environment & Lifestyle Close Health in Norway Close (...) Quality and Knowledge Close More topics Close The number of patients in hospitals and rehabilitation institutions at any time is large, and a considerable number of them need to use a urinary catheter. Catheter-associated urinary tract infection may (...) Urinary tract infection Top results for urinary tract infection - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like

2018 Trip Latest and Greatest

31. Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial Full Text available with Trip Pro

Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial Although uncomplicated urinary tract infections (UTIs) are often self-limiting, most patients will be prescribed antibiotic treatment. We assessed whether treatment with ibuprofen was non-inferior to pivmecillinam in achieving symptomatic resolution by day 4, with a non-inferiority margin of 10%.This was a randomized, controlled, double-blind non-inferiority trial

2018 EvidenceUpdates Controlled trial quality: predicted high

32. Urinary tract infection

Urinary tract infection Evidence Maps - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2

2018 Trip Evidence Maps

33. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. Full Text available with Trip Pro

Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. The use of nitrofurantoin and fosfomycin has increased since guidelines began recommending them as first-line therapy for lower urinary tract infection (UTI).To compare the clinical and microbiologic efficacy of nitrofurantoin and fosfomycin in women with uncomplicated cystitis.Multinational, open-label, analyst-blinded, randomized (...) clinical trial including 513 nonpregnant women aged 18 years and older with symptoms of lower UTI (dysuria, urgency, frequency, or suprapubic tenderness), a positive urine dipstick result (with detection of nitrites or leukocyte esterase), and no known colonization or previous infection with uropathogens resistant to the study antibiotics. Recruitment took place from October 2013 through April 2017 at hospital units and outpatient clinics in Geneva, Switzerland; Lodz, Poland; and Petah-Tiqva

2018 JAMA Controlled trial quality: predicted high

34. Accuracy of the Urinalysis for Urinary Tract Infections in Febrile Infants 60 Days and Younger Full Text available with Trip Pro

Accuracy of the Urinalysis for Urinary Tract Infections in Febrile Infants 60 Days and Younger Reports of the test accuracy of the urinalysis for diagnosing urinary tract infections (UTIs) in young febrile infants have been variable. We evaluated the test characteristics of the urinalysis for diagnosing UTIs, with and without associated bacteremia, in young febrile infants.We performed a planned secondary analysis of data from a prospective study of febrile infants ≤60 days old at 26 emergency

2018 EvidenceUpdates

35. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. Full Text available with Trip Pro

Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial. Meropenem-vaborbactam is a combination carbapenem/beta-lactamase inhibitor and a potential treatment for severe drug-resistant gram-negative infections.To evaluate efficacy and adverse events of meropenem-vaborbactam in complicated urinary tract infection (UTI), including acute pyelonephritis.Phase 3 (...) , multicenter, multinational, randomized clinical trial (TANGO I) conducted November 2014 to April 2016 and enrolling patients (≥18 years) with complicated UTI, stratified by infection type and geographic region.Eligible patients were randomized 1:1 to receive meropenem-vaborbactam (2g/2g over 3 hours; n = 274) or piperacillin-tazobactam (4g/0.5g over 30 minutes; n = 276) every 8 hours. After 15 or more doses, patients could be switched to oral levofloxacin if they met prespecified criteria for improvement

2018 JAMA Controlled trial quality: predicted high

36. Stigma and self-management: an Interpretative Phenomenological Analysis of the impact of chronic recurrent urinary tract infections after spinal cord injury Full Text available with Trip Pro

Stigma and self-management: an Interpretative Phenomenological Analysis of the impact of chronic recurrent urinary tract infections after spinal cord injury Qualitative, phenomenological design.Neurogenic bladder dysfunction and urinary tract infection (UTI) are common secondary consequences to neurological damage to the spinal cord. This study sought to establish the impact of chronic, recurrent UTIs on people with spinal cord injury (SCI).Community sample, United Kingdom.Twelve participants (...) effects on quality of life of people with a neurogenic bladder after SCI. People with SCI would benefit from additional assessment of the impact of recurrent UTIs, so that healthcare professionals can address specific concerns, such as the psychosocial impact of urinary incontinence and stigmatizing views. Additional support to enhance self-management and facilitate social participation should be provided.

2018 Spinal cord series and cases

37. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. Full Text available with Trip Pro

Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. To determine if trimethoprim use for urinary tract infection (UTI) is associated with an increased risk of acute kidney injury, hyperkalaemia, or sudden death in the general population.Cohort study.UK electronic primary care records from practices contributing to the Clinical Practice Research Datalink linked to the Hospital Episode Statistics database.Adults aged 65 and over

2018 BMJ

38. Urinary Tract Infection (Cystitis) - acute, uncomplicated

Urinary Tract Infection (Cystitis) - acute, uncomplicated Urinary Tract Infection (Cystitis) - acute, uncomplicated - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Urinary Tract Infection (Cystitis) - acute, uncomplicated An acute infection of the bladder (acute cystitis) Most commonly caused by Escherichia coli (80%), with the remaining 20 % caused by Staphylococcus species , proteus mirabilis, and enterococci Incidence (...) : Uncomplicated UTI : an infection caused by the usual pathogens in a patient with a normal urinary tract and with normal kidney function Complicated UTI : infection in a patient with risk factors for a severe infection or sequalae. All complicated UTIs must be referred. Examples include: Abnormal urinary tract due to an indwelling catheter, urinary obstruction or neurogenic bladder Immunosuppression (due to medications or health conditions, including poorly controlled diabetes) Impaired renal function All

2018 medSask

39. Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness

Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness | CADTH.ca Find the information you need Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness Fosfomycin for Lower Urinary Tract Infections: Comparative Clinical and Cost-Effectiveness Last updated: April 12, 2018 Project Number: RB1210-000 Product Line: Research Type: Drug (...) Report Type: Summary of Abstracts Result type: Report Question What is the comparative clinical effectiveness of fosfomycin compared with other antibiotics for the treatment of lower urinary tract infections? What is the comparative cost effectiveness of fosfomycin compared with other antibiotics for the treatment of lower urinary tract infections? Key Message Two non-randomized studies and one economic evaluation were identified regarding the use of Fosfomycin for the treatment of lower urinary

2018 Canadian Agency for Drugs and Technologies in Health - Rapid Review

40. Urinary tract infections and bladder management over the first year after discharge from inpatient rehabilitation. Full Text available with Trip Pro

Urinary tract infections and bladder management over the first year after discharge from inpatient rehabilitation. Secondary analysis of data from a prospective clinical trial of telephone counseling.To describe changes in bladder management and development of bladder-related complications in the first year after discharge from inpatient spinal cord injury (SCI) rehabilitation. To determine whether urinary tract infection (UTI) is associated with bladder management technique or severity of SCI (...) of follow-up, 19% of patients changed bladder management techniques. Among participants performing intermittent catheterization (IC), 20% had urinary incontinence weekly or more frequently. The cumulative incidence of UTI was 71% by the end of the study, and between 27 and 46% of subjects reported UTIs during each 3-month period. Subjects with spontaneous voiding reported significantly fewer UTIs than those using IC or indwelling catheterization (IDC), but there was no significant difference in UTIs

2018 Spinal cord series and cases Controlled trial quality: uncertain